here’s a busy week ahead for pharma and biotech in Washington — and beyond. Here’s what we’re looking out for:

A scheduled House vote on the ACA replacement bill

Criticism has rained down on the Republican health care plan since it was released two weeks ago. But GOP leaders are optimistic enough that they can pass the bill, the American Health Care Act, that they scheduled a floor vote in the House for Thursday. That’s seven years to the day that the bill it would replace, the Affordable Care Act, was signed into law by former President Obama.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy